Tag: FSD Pharma Inc
March 23, 2020
FSD Pharma Takes Steps to Mitigate the Impact of COVID-19 on its Cannabis Production Facility in Cobourg, Ontario
FSD Pharma Inc. has taken steps to mitigate the impact of the novel coronavirus SARS-CoV-2 pandemic on its wholly-owned subsidiary,... March 9, 2020
FSD Pharma Begins Phase 1 In-human Safety and Tolerability Study of Ultra Micro-Palmitolylethanolamide (PEA)
FSD Pharma Inc. announced receipt of approval from the Ethics Committee of the Alfred Hospital to initiate a Phase 1, placebo-controlled study. March 4, 2020
FSD Pharma to Ring the Opening Bell of the Canadian Securities Exchange On Friday, March 6, 2020
FSD Pharma Inc. (Nasdaq: HUGE, CSE: HUGE, FRA: 0K9A) will be ringing the opening bell at the Canadian Securities Exchange...
February 20, 2020
Cannara Insiders Form Buying Group to Fully Acquire FSD/FV Pharma’s Position in Cannara
Insiders' increase stake in Cannara coincides as cultivation poised to commence February 20, 2020
FSD Pharma Generates $7.7 Million in Proceeds and 670 Percent Return on Investment through Sale of Interest in Cannara Biotech
FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FRA:0K9A) today announced the sale of its 12% equity interest in Cannara Biotech Inc. February 5, 2020
FSD Pharma Chairman & CEO to Present at 22nd Annual BIO CEO & Investor Conference in NYC
FSD Pharma Inc. announces that Raza Bokhari, MD, Executive Co-Chairman and CEO will be participating in the 22nd Annual BIO CEO... February 4, 2020